Optimal response to imatinib therapy in a case of chronic myeloid leukemia with a concurrent loss of distal 22q

Optimal response to imatinib therapy in a case of chronic myeloid leukemia with a concurrent loss of distal 22q

The hallmark of diagnosing classical chronic myelogenous leukemia (CML) is the identification of Philadelphia (Ph) chromosome (Chr). However, some CML cases show additional structural/numerical chromosomal abnormalities involving either Ph Chr or more frequently other Chrs. Genetic alterations spari...

Full description

Bibliographic Details
Main Authors: Bayan Alqahtany, Fatma S Alqahtani, Osamah Khojah, Abdurahman Almaeen, Aamer Aleem
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of Applied Hematology
Subjects:
Additional chromosomal abnormality
chronic myelogenous leukemia
Philadelphia chromosome
Online Access:http://www.jahjournal.org/article.asp?issn=1658-5127;year=2017;volume=8;issue=4;spage=152;epage=155;aulast=Alqahtany

Internet

http://www.jahjournal.org/article.asp?issn=1658-5127;year=2017;volume=8;issue=4;spage=152;epage=155;aulast=Alqahtany

Similar Items